SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-197128
Filing Date
2014-05-13
Accepted
2014-05-13 16:35:24
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d690419d10q.htm 10-Q 569245
2 EX-31.1 d690419dex311.htm EX-31.1 5473
3 EX-31.2 d690419dex312.htm EX-31.2 5449
4 EX-32.1 d690419dex321.htm EX-32.1 3098
5 EX-32.2 d690419dex322.htm EX-32.2 3062
  Complete submission text file 0001193125-14-197128.txt   3901235

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sphs-20140331.xml EX-101.INS 538076
7 XBRL TAXONOMY EXTENSION SCHEMA sphs-20140331.xsd EX-101.SCH 37373
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20140331_cal.xml EX-101.CAL 62780
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20140331_def.xml EX-101.DEF 98630
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20140331_lab.xml EX-101.LAB 294620
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20140331_pre.xml EX-101.PRE 210681
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 14837838
SIC: 2834 Pharmaceutical Preparations